Fedratinib

Red

Brand Name(s):Inrebic

Indication:Primary myelofibrosis

Post polycythaemia vera myelofibrosis

Post essential thrombocythaemia myelofibrosis
(Adults)

Rationale:1,2

Considered:May-21

Review Date:May-26

Comments:
Treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis, who are JAK inhibitor naïve or have been treated with ruxolitinib.